Tural, D. Et Al. 2013. Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab. HEPATO-GASTROENTEROLOGY , vol.60, no.125 , 1035-1040.

Tural, D., Selcukbiricik, F., ERDAMAR ÇETİN, A. S., Ozkurt, C. U., Yanmaz, T., Mandel, N. M., ... Serdengecti, S.(2013). Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab. HEPATO-GASTROENTEROLOGY , vol.60, no.125, 1035-1040.

Tural, Deniz Et Al. "Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab," HEPATO-GASTROENTEROLOGY , vol.60, no.125, 1035-1040, 2013

Tural, Deniz Et Al. "Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab." HEPATO-GASTROENTEROLOGY , vol.60, no.125, pp.1035-1040, 2013

Tural, D. Et Al. (2013) . "Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab." HEPATO-GASTROENTEROLOGY , vol.60, no.125, pp.1035-1040.

@article{article, author={Deniz Tural Et Al. }, title={Association KRAS G13D Tumor Mutated Outcome in Patients with Chemotherapy Refractory Metastatic Colorectal Cancer Treated with Cetuximab}, journal={HEPATO-GASTROENTEROLOGY}, year=2013, pages={1035-1040} }